Could targeting immunometabolism be a way to control the burden of COVID-19 infection?

This review portrays the metabolic consequences of Covid-19 infection at different stages of the clinical syndrome. It also describes how events can change when patients with metabolic problems are infected and the effects that diet and nutrition might play to influence the outcome of infection. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Berber, Engin, Sumbria, Deepak, Rouse, Barry T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Institut Pasteur. Published by Elsevier Masson SAS. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816601/
https://www.ncbi.nlm.nih.gov/pubmed/33482357
http://dx.doi.org/10.1016/j.micinf.2021.104780
_version_ 1783638477060964352
author Berber, Engin
Sumbria, Deepak
Rouse, Barry T.
author_facet Berber, Engin
Sumbria, Deepak
Rouse, Barry T.
author_sort Berber, Engin
collection PubMed
description This review portrays the metabolic consequences of Covid-19 infection at different stages of the clinical syndrome. It also describes how events can change when patients with metabolic problems are infected and the effects that diet and nutrition might play to influence the outcome of infection. We also discuss the types of maneuvers that could be used to reshape metabolic events and question if this approach could be a practical therapy used alone or in combination with other approaches to reduce the burden of Covid-19 infection.
format Online
Article
Text
id pubmed-7816601
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Institut Pasteur. Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-78166012021-01-21 Could targeting immunometabolism be a way to control the burden of COVID-19 infection? Berber, Engin Sumbria, Deepak Rouse, Barry T. Microbes Infect Review This review portrays the metabolic consequences of Covid-19 infection at different stages of the clinical syndrome. It also describes how events can change when patients with metabolic problems are infected and the effects that diet and nutrition might play to influence the outcome of infection. We also discuss the types of maneuvers that could be used to reshape metabolic events and question if this approach could be a practical therapy used alone or in combination with other approaches to reduce the burden of Covid-19 infection. Institut Pasteur. Published by Elsevier Masson SAS. 2021 2021-01-20 /pmc/articles/PMC7816601/ /pubmed/33482357 http://dx.doi.org/10.1016/j.micinf.2021.104780 Text en © 2021 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Berber, Engin
Sumbria, Deepak
Rouse, Barry T.
Could targeting immunometabolism be a way to control the burden of COVID-19 infection?
title Could targeting immunometabolism be a way to control the burden of COVID-19 infection?
title_full Could targeting immunometabolism be a way to control the burden of COVID-19 infection?
title_fullStr Could targeting immunometabolism be a way to control the burden of COVID-19 infection?
title_full_unstemmed Could targeting immunometabolism be a way to control the burden of COVID-19 infection?
title_short Could targeting immunometabolism be a way to control the burden of COVID-19 infection?
title_sort could targeting immunometabolism be a way to control the burden of covid-19 infection?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816601/
https://www.ncbi.nlm.nih.gov/pubmed/33482357
http://dx.doi.org/10.1016/j.micinf.2021.104780
work_keys_str_mv AT berberengin couldtargetingimmunometabolismbeawaytocontroltheburdenofcovid19infection
AT sumbriadeepak couldtargetingimmunometabolismbeawaytocontroltheburdenofcovid19infection
AT rousebarryt couldtargetingimmunometabolismbeawaytocontroltheburdenofcovid19infection

Ejemplares similares